Cargando…

Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis

BACKGROUND: The clinicopathological and prognostic values of the cancer stem cell marker aldehyde dehydrogenase 1 (ALDH1) in ovarian cancer (OC) remain unknown. The aim of our meta-analysis was to evaluate ALDH1’s association with clinicopathological characteristics and its prognostic significance i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wenge, Zang, Chuanxin, Zhang, Tingting, Li, Jia, Liu, Ruijuan, Feng, Fubin, Lv, Qingliang, Zheng, Liang, Tian, Jinhui, Sun, Changgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892614/ https://www.ncbi.nlm.nih.gov/pubmed/29662319 http://dx.doi.org/10.2147/OTT.S160207

Ejemplares similares

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis
por: Zhang, Tingting, et al.
Publicado: (2018)

Comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy: a network meta-analysis
por: Zhang, Tingting, et al.
Publicado: (2018)

Integrated analysis of co‐expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer
por: Yao, Yan, et al.
Publicado: (2019)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"
por: Ieni, Antonio, et al.
Publicado: (2016)

Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Chen, Jinhuang, et al.
Publicado: (2015)

Comparative effectiveness of different chemotherapy regimens of advanced-stage Hodgkin lymphoma in adults: a network meta-analysis
por: Zhang, Tingting, et al.
Publicado: (2018)

Gastric Mucinous Cancer Histology: Clinicopathological Characteristics and Prognostic Value
por: Jian-Hui, Chen, et al.
Publicado: (2016)

Target Analysis and Mechanism of Podophyllotoxin in the Treatment of Triple-Negative Breast Cancer
por: Zhang, Wenfeng, et al.
Publicado: (2020)

Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population
por: Shinomiya, Hirotaka, et al.
Publicado: (2017)

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer
por: Blomqvist, Matias, et al.
Publicado: (2021)

Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
por: Li, Zhan, et al.
Publicado: (2017)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer
por: Panigoro, Sonar Soni, et al.
Publicado: (2020)

Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer
por: Nunes, Mariana, et al.
Publicado: (2022)

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014)

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma
por: Rezaee, Maryam, et al.
Publicado: (2021)

Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer
por: Kong, Yanan, et al.
Publicado: (2018)

The prognostic roles of ALDH1 isoenzymes in gastric cancer
por: Li, Kai, et al.
Publicado: (2016)

ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers
por: Chang, Bin, et al.
Publicado: (2009)

SNP mutation‐related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database
por: Gao, Chundi, et al.
Publicado: (2019)

ALDH1 as a prognostic marker for lymph node metastasis in OSCC
por: Götz, Carolin, et al.
Publicado: (2018)

Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
por: Yao, Yan, et al.
Publicado: (2022)

The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective study
por: Huang, Ruixia, et al.
Publicado: (2015)

Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014)

Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer
por: Yang, Rui, et al.
Publicado: (2016)

Clinicopathologic characteristics and prognostic factors of 63 gastric cancer patients with metachronous ovarian metastasis
por: Feng, Qiang, et al.
Publicado: (2013)

Clinicopathological Characteristics and Prognostic Prediction in Pseudomyxoma Peritonei Originating From Mucinous Ovarian Cancer
por: Fu, Fengxian, et al.
Publicado: (2021)

Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis
por: Feng, Fubin, et al.
Publicado: (2019)

Clinicopathological Significances and Prognostic Value of PPFIA4 in Colorectal Cancer
por: Fu, Fangmei, et al.
Publicado: (2023)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer" and the "Commentary by Antonio Ieni and Giovanni Tuccari"
por: Fargeas, Christine A., et al.
Publicado: (2016)

Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer
por: You, Qinghua, et al.
Publicado: (2015)

Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis
por: Han, Susu, et al.
Publicado: (2019)

The association between statin use and endometrial cancer survival outcome: A meta-analysis
por: Li, Jia, et al.
Publicado: (2018)

Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer
por: Kubeček, Ondřej, et al.
Publicado: (2021)

Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables
por: Rykala, Jan, et al.
Publicado: (2011)

Dysregulated Expression of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Cancer
por: Huang, Xin, et al.
Publicado: (2019)

Clinicopathologic Analysis of Cathepsin B as a Prognostic Marker of Thyroid Cancer
por: Kim, Eun-Kyung, et al.
Publicado: (2020)

Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis
por: Zhang, Zhihao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s9sas3g6lt7gm7373cpdhr62u7